Follow
Thomas Berg
Thomas Berg
Professor der Medizin
Verified email at medizin.uni-leipzig.de
Title
Cited by
Cited by
Year
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ...
Nature genetics 41 (10), 1100-1104, 2009
23722009
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ...
Gastroenterology 138 (4), 1338-1345. e7, 2010
14612010
ABT-450/r–ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis
F Poordad, C Hezode, R Trinh, KV Kowdley, S Zeuzem, K Agarwal, ...
New England Journal of Medicine 370 (21), 1973-1982, 2014
11872014
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
S Jonas, WO Bechstein, T Steinmüller, M Herrmann, C Radke, T Berg, ...
Hepatology 33 (5), 1080-1086, 2001
10572001
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
T Berg, M von Wagner, S Nasser, C Sarrazin, T Heintges, T Gerlach, ...
Gastroenterology 130 (4), 1086-1097, 2006
6972006
Peginterferon-α-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C
M von Wagner, M Huber, T Berg, H Hinrichsen, J Rasenack, T Heintges, ...
Gastroenterology 129 (2), 522-527, 2005
5792005
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
JG McHutchison, G Dusheiko, ML Shiffman, M Rodriguez-Torres, S Sigal, ...
New England Journal of Medicine 357 (22), 2227-2236, 2007
5602007
Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection
F van Bömmel, T Wünsche, S Mauss, P Reinke, A Bergk, D Schürmann, ...
Hepatology 40 (6), 1421-1425, 2004
4802004
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
T Berg, C Sarrazin, E Herrmann, H Hinrichsen, T Gerlach, R Zachoval, ...
Hepatology 37 (3), 600-609, 2003
4032003
The system can't perform the operation now. Try again later.
Articles 1–9